Prof Robert Coleman speaks to ecancer in an online interview for the virtual BGICC 2021 meeting about the evolving medical treatment in advanced/recurrent endometrial cancer

He explains that over the years there has been steady improvement in bringing new therapies into the endometrial cancer landscape but that a therapeutic ceiling had somewhat been reached.

Prof Coleman then highlights the discovery of the different molecular characteristics of endometrial cancer and how they can be leveraged using treatments such as immunotherapy.